DSGN Competitors & Alternatives
Compare Design Therapeutics Inc with similar stocks in the same industry
Biotechnology
DSGN
Main Stock$14.63
Tradestie Score
40
Market Cap
$386.68M
Analyst Upside
+43.5%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
|
$4.95
|
$952.74M | - | 40 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$3.13
|
$951.83M | - | 50 | Compare |
|
ANL
ANL
|
$15.21
|
$946.33M | - | 47 | Compare |
|
MNMD
Mind Medicine (MindMed) Inc. Common Shares
|
$15.02
|
$938.16M | - | 43 | Compare |
|
ZBIO
Zenas BioPharma, Inc. Common Stock
|
$31.12
|
$931.48M | - | 43 | Compare |
|
RLAY
Relay Therapeutics, Inc. Common Stock
|
$18.87
|
$917.23M | - | 64 | Compare |
|
OCS
Oculis Holding AG Ordinary shares
|
$10.56
|
$910.64M | - | 45 | Compare |
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$22.81
|
$906.29M | - | 51 | Compare |
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$37.01
|
$903.54M | - | 46 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$92.38
|
$900.91M | - | 63 | Compare |
More DSGN Analysis
Data updated: Sep 11, 2026 | Industry: Biotechnology (SIC 2834)
235 stocks in this industry